The company has developed innovative therapies based on a deep understanding of axon regeneration and neuronal signaling pathways, with a commitment to transforming the lives of patients afflicted with these disorders. BioAxone's passionate management team, backed by 20 years of pioneering research, is focused on developing a pipeline of drugs that target nerve repair and regeneration.